These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 17066447)

  • 1. The involvement of hypoxia-inducible factor-1alpha in the susceptibility to gamma-rays and chemotherapeutic drugs of oral squamous cell carcinoma cells.
    Sasabe E; Zhou X; Li D; Oku N; Yamamoto T; Osaki T
    Int J Cancer; 2007 Jan; 120(2):268-77. PubMed ID: 17066447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive oxygen species produced by the knockdown of manganese-superoxide dismutase up-regulate hypoxia-inducible factor-1alpha expression in oral squamous cell carcinoma cells.
    Sasabe E; Yang Z; Ohno S; Yamamoto T
    Free Radic Biol Med; 2010 May; 48(10):1321-9. PubMed ID: 20188165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of GLUT-1 inhibits sensitization of oral cancer cells to cisplatin during hypoxia.
    Shimanishi M; Ogi K; Sogabe Y; Kaneko T; Dehari H; Miyazaki A; Hiratsuka H
    J Oral Pathol Med; 2013 May; 42(5):382-8. PubMed ID: 23227892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
    Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Impact of RNA interference targeting hypoxia-inducible factor-1alpha on chemosensitivity in esophageal squamous cell carcinoma cells under hypoxia].
    Wu XA; Sun Y; Fan QX; Wang LX; Wang RL; Zhang L
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2640-4. PubMed ID: 18162154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of hypoxia on the chemotherapeutic sensitivity of human ovarian cancer cells to paclitaxel and its mechanism].
    Huang L; Zhang QH; Ao QL; Xing H; Lu YP; Ma D
    Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):96-100. PubMed ID: 17645840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism.
    Ai Z; Lu Y; Qiu S; Fan Z
    Cancer Lett; 2016 Apr; 373(1):36-44. PubMed ID: 26801746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation protective effect of hypoxia-inducible factor-1α (HIF-1α) on human oral squamous cell carcinoma cell lines.
    Hosokawa Y; Okumura K; Terashima S; Sakakura Y
    Radiat Prot Dosimetry; 2012 Nov; 152(1-3):159-63. PubMed ID: 22927657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA interference-mediated downregulation of hypoxia-inducible factor-1α inhibits angiogenesis and survival of oral squamous cell carcinoma in vitro and in vivo.
    Zhou H; Fei W; Bai Y; Zhu S; Luo E; Chen K; Hu J
    Eur J Cancer Prev; 2012 May; 21(3):289-99. PubMed ID: 22113109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-induced increases in A549/CDDP cell drug resistance are reversed by RNA interference of HIF-1α expression.
    Min L; Chen Q; He S; Liu S; Ma Y
    Mol Med Rep; 2012 Jan; 5(1):228-32. PubMed ID: 21964646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia enhances CXCR4 expression by activating HIF-1 in oral squamous cell carcinoma.
    Ishikawa T; Nakashiro K; Klosek SK; Goda H; Hara S; Uchida D; Hamakawa H
    Oncol Rep; 2009 Mar; 21(3):707-12. PubMed ID: 19212630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIF-1α inhibition reverses multidrug resistance in colon cancer cells via downregulation of MDR1/P-glycoprotein.
    Chen J; Ding Z; Peng Y; Pan F; Li J; Zou L; Zhang Y; Liang H
    PLoS One; 2014; 9(6):e98882. PubMed ID: 24901645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation and hypoxia linked to renal injury by CCAAT/enhancer-binding protein δ.
    Yamaguchi J; Tanaka T; Eto N; Nangaku M
    Kidney Int; 2015 Aug; 88(2):262-75. PubMed ID: 25692954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between the polymorphisms in exon 12 of hypoxia-inducible factor-1alpha and the clinicopathological features of oral squamous cell carcinoma.
    Shieh TM; Chang KW; Tu HF; Shih YH; Ko SY; Chen YC; Liu CJ
    Oral Oncol; 2010 Sep; 46(9):e47-53. PubMed ID: 20656543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia inducible factor-alpha expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma.
    Liang X; Yang D; Hu J; Hao X; Gao J; Mao Z
    Anticancer Res; 2008; 28(3A):1659-66. PubMed ID: 18630523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDAC2 promotes cell migration/invasion abilities through HIF-1α stabilization in human oral squamous cell carcinoma.
    Chang CC; Lin BR; Chen ST; Hsieh TH; Li YJ; Kuo MY
    J Oral Pathol Med; 2011 Aug; 40(7):567-75. PubMed ID: 21332579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1alpha.
    Chintala S; Tóth K; Cao S; Durrani FA; Vaughan MM; Jensen RL; Rustum YM
    Cancer Chemother Pharmacol; 2010 Oct; 66(5):899-911. PubMed ID: 20066420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIF-1α siRNA and cisplatin in combination suppress tumor growth in a nude mice model of esophageal squamous cell carcinoma.
    Liao HY; Wang GP; Gu LJ; Huang SH; Chen XL; Li Y; Cai SW
    Asian Pac J Cancer Prev; 2012; 13(2):473-7. PubMed ID: 22524809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SUVmax of FDG-PET correlates with the effects of neoadjuvant chemoradiotherapy for oral squamous cell carcinoma.
    Miyawaki A; Ikeda R; Hijioka H; Ishida T; Ushiyama M; Nozoe E; Nakamura N
    Oncol Rep; 2010 May; 23(5):1205-12. PubMed ID: 20372831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia induced paclitaxel resistance in human ovarian cancers via hypoxia-inducible factor 1alpha.
    Huang L; Ao Q; Zhang Q; Yang X; Xing H; Li F; Chen G; Zhou J; Wang S; Xu G; Meng L; Lu Y; Ma D
    J Cancer Res Clin Oncol; 2010 Mar; 136(3):447-56. PubMed ID: 19760195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.